Delivery Order SPE2DB20D2014-SPE2DB25FC02B
Award Date
5/21/25
Potential Completion Date
5/22/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,270.29, is for the delivery of 90-count tablets of the medication Letrozole 2.5 mg. The contract has an ultimate completion date of May 5, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Letrozole 2.5 mg tablets. The contract has a ceiling value of $2,040.45 and is a firm fixed-price delivery order that runs through March 6, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,275.54, is for the delivery of Letrozole 2.5 mg tablets. The contract has a firm fixed price pricing type and a period of performance through November 4, 2024. The contract was not designated under any set-aside program, indicating open competition. Amerisourcebergen holds a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $13,672.24 firm-fixed-price delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,566,110,874 Letrozole 2.5 mg tablets. The order has an ultimate completion date of October 16, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, valued at up to $999,999,999 through December 2025, for the provision...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 90-count packages of the prescription drug Letrozole 2.5 mg tablets, with a total ceiling value of $4,736.41 and a performance period ending on April 28, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a delivery order with a firm fixed price and a ceiling value of $4,908.84. The contract is for the delivery of LETROZOLE 2.5 MG TABLET 90S, a pharmaceutical product, with a period of performance through May 23, 2025. The contract is not set aside for any special designation. Amerisourcebergen Drug Corp...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Letrozole 2.5 mg tablets, with a ceiling value of $2,774.22 and a period of performance running through February 18, 2025. The contract is a firm-fixed-price delivery order that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Letrozole 2.5 mg tablets. The $4,972.14 firm fixed-price delivery order has an ultimate completion date of October 17, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. The company holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Medical Supply Chain division of the Defense agency to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,081.68 firm fixed price delivery order is for the supply of 90 tablets of the drug Letrozole 2.5mg. The contract has an ultimate completion date of May 15, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Letrozole 2.5 mg tablets, a medication used to treat breast cancer. The contract is a firm fixed-price, non-set-aside delivery order with a ceiling value of $2,623.08 and a period of performance through May 2, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery...